Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MTA
13351
CALL
Metalla Royalty & Streaming
MTA
$871M
| $14.8K | ﹤0.01% |
5,900
+5,700
| +2,850% | +$18.1K |
2024 Q3
1 quarter
|
|
13352
PUT
Thryv Holdings
THRY
$66.2M
| $14.8K | ﹤0.01% |
1,000
-400
| -29% | -$6.3K |
2024 Q2
2 quarters
|
|
13353
CALL
Achieve Life Sciences
ACHV
$723M
| $14.8K | ﹤0.01% |
4,200
-18,400
| -81% | -$83.4K |
2024 Q1
3 quarters
|
|
|
HTO
13354
CALL
H2O America
HTO
$2.45B
| $14.8K | ﹤0.01% |
300
-100
| -25% | -$5.51K |
2023 Q4
4 quarters
|
|
13355
CALL
First Mid Bancshares
FMBH
$1.32B
| $14.7K | ﹤0.01% |
+400
| New | +$15.9K |
2024 Q4
0 quarters
|
|
|
JBIO
13356
Jade Biosciences
JBIO
$895M
| $14.7K | ﹤0.01% |
+159
| New | +$13.7K |
2024 Q4
0 quarters
|
|
13357
CALL
Lantern Pharma
LTRN
$14M
| $14.7K | ﹤0.01% |
4,600
-35,200
| -88% | -$121K |
2022 Q3
9 quarters
|
|
13358
CALL
Park Aerospace
PKE
$654M
| $14.7K | ﹤0.01% |
1,000
+700
| +233% | +$10.1K |
2024 Q3
1 quarter
|
|
13359
Omega Healthcare
OHI
$13.7B
| $14.6K | ﹤0.01% |
387
-1,269
| -77% | -$50.7K |
2015 Q2
38 quarters
|
|
|
CON
13360
PUT
Concentra Group Holdings
CON
$4.62B
| $14.6K | ﹤0.01% |
740
+640
| +640% | +$13.2K |
2024 Q3
1 quarter
|
|
13361
PUT
LXP Industrial Trust
LXP
$3.59B
| $14.6K | ﹤0.01% |
360
+220
| +157% | +$10.2K |
2022 Q4
8 quarters
|
|
13362
CALL
IHS Holding
IHS
$2.86B
| $14.6K | ﹤0.01% |
5,000
-600
| -11% | -$1.82K |
2024 Q3
1 quarter
|
|
13363
CALL
Cytosorbents Corp
CTSO
$12.5M
| $14.6K | ﹤0.01% |
800
+30
| +4% | +$589 |
2024 Q2
2 quarters
|
|
|
TGB
13364
PUT
Trekor Metals
TGB
$3.26B
| $14.6K | ﹤0.01% |
7,500
-95,100
| -93% | -$210K |
2022 Q2
10 quarters
|
|
13365
PUT
Sensus Healthcare
SRTS
$48.1M
| $14.5K | ﹤0.01% |
2,100
+1,300
| +163% | +$9.53K |
2024 Q3
1 quarter
|
|
13366
PUT
GraniteShares 1.25x Long TSLA Daily ETF
TSL
$11.6M
| $14.5K | ﹤0.01% |
800
-3,800
| -83% | -$52.9K |
2024 Q3
1 quarter
|
|
13367
CALL
PharmaCyte Biotech
PMCB
$4.19M
| $14.4K | ﹤0.01% |
+9,300
| New | +$16K |
2024 Q4
0 quarters
|
|
13368
PUT
First Internet Bancorp
INBK
$234M
| $14.4K | ﹤0.01% |
400
-3,500
| -90% | -$133K |
2022 Q4
8 quarters
|
|
13369
Moving iMage Technologies
MITQ
$5.5M
| $14.3K | ﹤0.01% |
22,026
-23,238
| -51% | -$14.4K |
2024 Q3
1 quarter
|
|
13370
PUT
China Yuchai International
CYD
$1.2B
| $14.3K | ﹤0.01% |
+1,500
| New | +$15.8K |
2024 Q4
0 quarters
|
|
13371
PUT
Afya
AFYA
$1.18B
| $14.3K | ﹤0.01% |
900
+700
| +350% | +$11.5K |
2024 Q2
2 quarters
|
|
13372
PUT
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$7.69B
| $14.3K | ﹤0.01% |
+1,100
| New | +$14.8K |
2024 Q4
0 quarters
|
|
13373
CALL
NatWest
NWG
$69.3B
| $14.2K | ﹤0.01% |
1,400
+700
| +100% | +$6.93K |
2024 Q3
1 quarter
|
|
13374
Verrica Pharmaceuticals
VRCA
$74M
| $14.2K | ﹤0.01% |
+2,029
| New | +$22.3K |
2024 Q4
0 quarters
|
|
|
AIFU
13375
CALL
AIFU Inc
AIFU
$61.2M
| $14.2K | ﹤0.01% |
32
-19
| -37% | -$10.1K |
2024 Q2
2 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.